Members of the genus Cronobacter are an emerging group of opportunist Gram-negative pathogens. This genus was previously thought to be a single species, called Enterobacter sakazakii. Cronobacter spp. typically affect low-birth-weight neonates, causing life-threatening meningitis, sepsis and necrotizing enterocolitis. Outbreaks of disease have been associated with contaminated infant formula, although the primary environmental source remains elusive. Advanced understanding of these bacteria and better classification has been obtained by improved detection techniques and genomic analysis. Research has begun to characterize the virulence factors and pathogenic potential of Cronobacter. Investigations into sterilization techniques and protocols for minimizing the risk of contamination have been reviewed at national and international forums. In this review, we explore the clinical impact of Cronobacter neonatal and pediatric infections, discuss virulence and pathogenesis, and review prevention and treatment strategies.
INTRODUCTION
Cronobacter is an emerging genus of opportunistic Gram-negative pathogens associated with potentially fatal neonatal infections, including meningitis, sepsis and necrotizing enterocolitis (NEC). 1 These infections typically affect our smallest and most vulnerable patients. Historically, Cronobacter spp. were thought to be a single species known as Enterobacter sakazakii. 2 With improved culture and identification techniques, including partial 16S ribosomal DNA, hsp60 sequencing and polyphasic analysis, Cronobacter was recognized as its own genus within the Enterobacteriaceae family. 3 Subsequent genomic sequencing data confirmed the change in taxonomy. 4 The first Cronobacter genome to be sequenced was that of an isolate recovered from a neonatal unit in Tennessee after an outbreak in 2001. 5 Sequencing revealed a single chromosome of 4.4 Mb and 2 plasmids. 4 Currently the genus contains eight species that include C. sakazakii, C. malonaticus, C. turicensis, C. muytjensii, C. dublinensis, C. condiment and C. universalis. 3 In this review, we will explore the clinical impact of Cronobacter neonatal and pediatric infections, discuss virulence and pathogenesis and review prevention and treatment strategies.
CLINICAL IMPACT
The sentinel case of Cronobacter infection was reported in 1961 by Urmenyi and Franklyn. 6 In that description of terminal neonatal meningitis, the bacterial culprit was described as a 'yellow pigmented Enterobacter cloacae'. This infectious entity was given species-status in 1980 2 (E. sakazakii), and subsequently redefined as the genus Cronobacter in 2008. 7 As this initial description there are now in excess of 150 reported cases of Cronobacter-related infections. 8 The most commonly reported consequences of infection are meningitis, NEC and sepsis. 9, 10 Other resultant diseases have been reported, including conjunctivis, urinary tract infections, diarrhea, tonsillitis and osteomyelitis. 11, 12 Outbreaks are most commonly sporadic, but have occurred within clusters in a single clinical setting. 10 Cronobacter neonatal infection rates remain low and are reported in the USA as one Cronobacter infection per 100 000 infants, 8.7 per 100 000 low-birth-weight neonates, and one Cronobacter infection per 10 660 very lowbirth-weight neonates. 13 It is suggested that the incidence of infection may be under-reported in developing and less developed countries, perhaps due to a lack of medical microbiology analysis facilities.
8 Figure 1 demonstrates the worldwide distribution of reported cases, the majority are within the United States; however, widespread locations are noted. These data were generated from multiple reports worldwide. 8, [14] [15] [16] [17] It is not the frequency of these infections, but rather their impact, lethality and vulnerable population affected, which makes this a serious health issue. Cronobacter-induced neonatal disease had been previously cited to have a mortality of 80%. 18 Friedmann et al. 8 analyzed the microbiologically confirmed cases and reported an overall lethality of Cronobacter infection as 26.9%. Cronobacter-associated meningitis is fatal in almost 42% of patients and Cronobacter-associated sepsis and NEC lethality rates are cited at B10 and 20%, respectively. 8 Meningeal Cronobacter infection is established between the fourth and fifth post partum days, and can be fatal within hours to days following the initial clinical symptom. 9 Even when infants survive the acute insult, long-term neurological delay and poor lifelong outcomes may occur in more than 74% of survivors. 19 Although the majority of affected patients are less than 3 months of age; a study from the United Kingdom found infants up to 11 months with Cronobacter-associated meningitis. 20 Although older populations may be infected including the elderly, 21 premature infants and those weighing less than 2.5 kg remain the most susceptible. 8 
PATHOGENESIS AND VIRULENCE
Virulence is the degree of pathogenesis of a species or its ability to induce disease in a host. A variety of in vitro and in vivo models have been used to investigate the mechanisms by which Cronobacter induces disease. [22] [23] [24] Although the distinct mechanisms are not fully elucidated, promising data from the genome sequencing effort have highlighted several potential virulence factor candidates. 25 As described, the genome of Cronobacter sakazakii has B4392 genes. 4 Of these, 223 genes were annotated as relevant to virulence and disease. 4 Of the 21 genes unique to C. sakazakii, the resultant encoded proteins have been identified to have a role in pilus assembly, photransferase systems, acid transport and toxin/antitoxin transport systems. 26 Outer membrane protein A, encoded by the ompA gene, is one of the best characterized virulence factors. 27 It is required for binding and invasion of brain endothelial cells, which are necessary steps during development of meningitis. 28 The ompA-encoded gene is thought to be universally present in Cronobacter. OmpA is also of crucial importance in the virulence of another meningitis causing bacteria, Escherichia coli K1. 29 Although the sequences of ompA between various strains are different, the mechanism of attachment and invasion of Cronobacter and E.coli K1 at the blood-brain barrier may theoretically be similar. E.coli K1 has not been specifically associated with outbreaks of NEC. Cronobacter virulence is also associated with the production of an enterotoxinlike compound, which may further enhance virulence and its translocation across the gut and blood-brain barrier. 30 The role of this toxin may act in a similar fashion to lipopolysaccaride, mediating Toll-like receptor 4 activation and activating a host inflammatory response. The production of an enterotoxin was established in a suckling mouse assay. 30 Intraperitoneal injection of Cronobacter and oral administration both result in the clinical manifestations of disease; injection of 10 8 colony forming units resulted in death regardless of the strain used. 30 The ability of Cronobacter to induce death in a mouse model through the oral administration appears both strain and dose-dependent. The role of Cronobacter enterotoxin remains an area of active investigation. We have previously demonstrated that Cronobacter is able to adhere to intestinal epithelial cells both in cultured cell lines and in the gavage-fed neonatal rat pup model of NEC 22 This association results in increased epithelial apoptosis and loss of epithelial barrier integrity. 31 Our prior data suggest that the normal balance of cell proliferation, restitution and programed cell death may be altered in the presence of Cronobacter infection. Although programed cell death (apoptosis) is an important aspect of the gut health and maintenance, a greater degree of apoptosis results in the loss of mucosal integrity, intestinal barrier compromise and permits the passage of bacteria into the host environment. Studies using an in vitro epithelial cell line demonstrated that some strains may be able to disrupt gap junctions between cells. 32 Loss of normal intestinal integrity is a key feature in the development of NEC. 33 Figure 2 outlines a possible model for Cronobacter infection after oral inoculation. The bacteria adhere to the intestinal epithelial barrier, causing barrier degradation and soliciting an inflammatory response in the host. This inflammatory response is characterized by the production of cytokines, which in turn recruit immune cells to the site. Once the barrier is breached Cronobacter spp. may enter the blood stream, resulting in sepsis and meningitis.
In addition to facilitating host damage, virulence factors may provide protection from the detection and response of the innate and adaptive host immune system. Recently, Franco et al. 34 demonstrated resistance to complement-mediated killing in the presence of a plasmid-encoded protein.
Cronobacter may also effect alterations in immune cell recruitment in the intestine of affected subjects. 35 Cronobacter has been shown to trigger an inflammatory cascade and inducible nitric oxide synthase, and interleukin-6 have been implicated in facilitating the downstream affects. 22, 35 Both nitric oxide and interleukin-6 have pro-apoptotic activity, and are found at high levels in animal models of Cronobacter infection. In addition to causing local barrier disruption, these cytokines may have profound effects on systemic immunity and inflammation. 36 
ENVIRONMENTAL SOURCES Contamination of powder infant formula (PIF) leading to
Cronobacter-associated disease garnered attention both within the scientific literature and popular press. 37, 38 The natural environment of Cronobacter remains unclear but soil samples, powdered milk substitutes, processed cheese, meats, herbs and spices, the gut of a Mexican fruit fly and the stable fly have all been identified as containing the bacteria. 39, 40 Although the stable fly was thought to have importance as a potential vector, further investigation revealed that the true incidence of Cronobacter in this species was very low and thus it was an unlikely candidate. Typically, Cronobacter is not present within the normal mammalian intestinal tract, and there is only a single Figure 1 . Worldwide distribution of reported cases of neonatal Cronobacter spp. infection. PubMed was queried for all reports of E. sakazakii or Cronobacter infant and pediatric infection. Each case was grouped based on the country, in which it was recorded. Geographical locations of cases are summarized in pie chart format. The others segment include Canada, India, Korea, the Netherlands, New Zealand and Slovenia. The majority of cases are reported in the USA (27.9%).
report of Cronobacter being isolated from a human vaginal canal, 41 thereby making vertical transmission less likely. The prospect of contaminated PIF constitutes an intolerable mainline access to the most at risk populations. In 1990 an outbreak of Cronobacter neonatal infection was clearly linked to contaminated PIF. 42 Two unopened cans were found to contain Cronobacter spp. One hundred and forty-one breast milk substitutes from 35 countries have identified Cronobacter spp. in over 20 samples. 43 The concentrations ranged from 0.36 colony forming units/100 g to 66 colony forming units/100 mg of PIF. More recently, Cronobacter was isolated from 2 of 82 PIF, 5 of 49 weaning foods, 3 of 72 milk powders, 40 of 122 herbs and spices and 15 of 66 other dry food ingredients. 44 A total of seven countries participated in a study to determine the incidence of Cronobacter in desiccated products made for infant consumption. 17 These countries included Brazil, England, Mexico, Indonesia, Jordan, Korea, Portugal and Malaysia. 45 They reported the isolation of Cronobacter spp. from 1 of 84 samples of follow-up formula and 30 of 203 weaning foods. Therefore, it is clear that Cronobacter spp. is recoverable from the desiccated state in a number of powdered food products that are provided to infants. In December of 2011, the Food and Drug Administration reported a series of neonatal disease outbreaks in Florida, Illinois, Missouri and Oklahoma. 46 Although temporally related, the sources of these outbreaks appear to be different, and unlike the 1990 cases, factory-sealed PIF is not the likely source. Contamination of the product after opening appears more likely. PIF is a clean but not sterile product that must conform to specified international microbiological criteria. PIF is manufactured through a process of high temperature heating and desiccation. C. sakazakii has been demonstrated to have remarkable thermotolerance, 47 and can withstand temperatures up to 60 1C for limited periods of time. 48 Additionally, Cronobacter may survive up to 12 months at 4 1C.
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Reconstituted formula is an excellent substrate for Cronobacter. There are also reports of Cronobacter surviving desiccated states for several weeks and being resistant to osmotic stresses. 50 It further appears that clinically relevant strains are the most heat and desiccation resistant, perhaps having provided them with a survival benefit and the ability to reach their host. It is important to both identify potential environmental contamination and develop strategies to eliminate Cronobacter from PIF when present. The FAO/WHO (Food and Agriculture Organization and the World Health Organization) recommends that formula be reconstituted with hot water (4 70 1C) 51 in an effort to reduce the bacterial load and reduce the incidence of Cronobacter-associated infections. 52 However, certain nutritional elements including vitamins may be altered or lost after heating to such high temperatures. Inappropriate storage and temperature control after reconstitution, and poor bottle and plastic nipple cleanliness are a potential reservoir of infection. The ability of Cronobacter to form biofilms may also provide it protection to host defenses and the ability to survive regular clinical sterilization methods. 53 Other sterilization strategies have been investigated. 54 Reports have shown that essential oils and polyphenols are effective biocides in a laboratory environment. 55 However, the majority of these compounds are toxic to human beings, and elevated levels with PIF would likely pose their own threat. The addition of ultrasound or ultraviolet radiation to heating protocols may improve sterilization processes. 56, 57 The efficacy of standard detergents has also been investigated, 53 and in general Cronobacter appear fairly resistant to routine cleaning techniques. Ionizing radiation has been investigated as a strategy to reduce the presence of bacteria in PIF. 58 Doses of up to 10 kGy have demonstrated a reduction in pathogens without causing disturbance of the quality, safety or composition of the formula. 59 These data appear promising; however, desiccated Cronobacter exhibit increased radiation-resistance when compared with nondesiccated cells. Several preventative strategies have been investigated in vivo. We were able to demonstrate that pretreatment with the probiotic bacteria Lactobacillus decreased the severity of C. sakazakii-induced NEC in an animal model. 60 Improved intestinal barrier health and decreased apoptosis were also noted. Lactobacillus is a lactic acid producing bacteria, and the presence of lactic acid in the presence of copper has been shown to inhibit Cronobacter spp. in vitro. 61 Other investigators have suggested that prebiotics may inhibit Cronobacter intestinal adherence, thereby providing clinical protection from disease. 62 The current recommendations regarding formula preparation are summarized in Table 1 . It has not been proved definitively that hospital staff are themselves not a vector for Cronobacter Figure 2 . Model of Cronobacter infection following ingestion of contaminated PIF. Oral inoculation of Cronobacter into an infant after ingestion of contaminated PIF. The bacteria release enterotoxin ( þ E), which may increase bacterial virulence and disrupt the intestinal barrier causing necrotizing enterocolitis. Cronobacter adheres to the intestinal layer. In the setting of a disrupted epithelial barrier, microbes traverse the mucosal layers, gaining access to lower immune and nonimmune cell populations. Mucosal microvascular endothelial cells, which represent the final anatomic border before the host's microcirculation, sense microbial antigens and respond rapidly by mounting an immune response. Cronobacter may enter to vasculature thereby gaining access to the blood-brain barrier resulting in bacteremia and meningitis.
transmission. Unfortunately, it is recognized that hospital personnel may ignore appropriate hygiene practices and contribute to the spread of infection. 63 Therefore, adherence to strict hand washing and contact isolation of affected and susceptible infants should be employed. Table 1 outlines preventative strategies that are recommended to combat the risks of Cronobacter contamination of PIF.
THERAPEUTIC STRATEGIES
Prevention is preferable, however, once Cronobacter infection has been diagnosed, prompt and appropriate antibiotic therapy should be initiated. Standard supportive measures typically employed in the management of neonatal sepsis, meningitis and NEC should be maintained. The majority of antibiotic data pertaining to antibiotic susceptibility and resistance profiles of Cronobacter were determined on established Enterobacter species such as E. cloacae, and later the specific antibiotic profiles of various E. sakazakii strains. Interestingly, no natural resistance to cephalosporins was detected in wild-type populations of Cronobacter, and these strains appear to lack b-lactamases.
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C. sakazakii, typical of most Enterobacteriacae, has natural resistance to lincosamides, glycopeptides, streptogramins and fusidic acids. However, the emergence of antibiotic resistance patterns has been reported. 65 Currently, broad-spectrum antibiotics and supportive care are recommended. In cases of clinical infection, antibiotic sensitivity profiling should be sought, in order to administer the most effective therapy.
CONCLUSION
Since the first report of a 'yellow pigmented' bacterial infection, our understanding of Cronobacter has greatly improved. Cronobacter spp. are especially interesting because no single bacterium has been found to meet Koch's postulates for NEC in most circumstances. Both neonatal meningitis and NEC are devastating diseases, with poor long-term prognosis in survivors.
Although great strides have been made in successfully identifying Cronobacter, we lack full understanding of its environment, transmission, pathogenesis and treatment. Work both in vitro and in vivo will hopefully continue to elucidate the underpinning of Cronobacter-related infection. Furthermore, better regulation and preventative strategies will continue to aid in the control of the introduction of this potentially fatal neonatal pathogen to human food sources. 
